US Patent 11884656 Pyrrole derivatives as PLK1 inhibitors
Patent 11884656 was granted and assigned to Sentinel Oncology Limited on January, 2024 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 11884656 Pyrrole derivatives as PLK1 inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.